Showing 501-510 of 1328 results for "".
Monoclonal Antibodies and Migraine: What the Neurologist Needs to Know
https://practicalneurology.com/diseases-diagnoses/headache-pain/monoclonal-antibodies-and-migraine-what-the-neurologist-needs-to-know/30361/As a new age in headache medicine is set to begin, it is incumbent upon neurologists to become better familiarized with and explore the implications of monoclonal antibodies in patient care.Letters
https://practicalneurology.com/columns/practice-management/letters/30698/Epilepsy Essentials: Seizure Disorders and Commercial Motor Vehicle Operators
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/epilepsy-essentials-seizure-disorders-and-commercial-motor-vehicle-operators/30858/Clinical neurologists should be familiar with regulations regarding commercial drivers' qualifications to drive and the role of third party examiners.Can the Private Practice Survive in the Age of Consolidation?
https://practicalneurology.com/columns/practice-management/can-the-private-practice-survive-in-the-age-of-consolidation/30326/In the rapidly changing health care economy, increasing regulation and the expanding influence of third-party payers are diminishing the physician's role.The Benefits of Collaborative Care
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/the-benefits-of-collaborative-care/30252/Stroke Snapshot: Mood Disorders After Experiencing a Stroke
https://practicalneurology.com/diseases-diagnoses/stroke/stroke-snapshot-mood-disorders-after-experiencing-a-stroke/30176/Mood disorders are significant comorbidities and frequently undertreated, despite growing evidence of benefits of treatment.Muscle Cramps
https://practicalneurology.com/diseases-diagnoses/neuromuscular/muscle-cramps/31559/Reliable and validated outcome measures and new treatments are needed.Immune-Mediated Cerebellar Ataxias
https://practicalneurology.com/diseases-diagnoses/movement-disorders/immune-mediated-cerebellar-ataxias/31708/Cerebellar ataxia may be a prominent feature in autoimmune encephalitis and paraneoplastic syndromes.Hyperkinetic Movement Disorders
https://practicalneurology.com/diseases-diagnoses/movement-disorders/hyperkinetic-movement-disorders/30248/New treatments were approved in 2017 for tardive dyskinesia, Parkinson's dyskinesia, and Huntington's chorea.Friedreich Ataxia: Pathophysiology and Treatment
https://practicalneurology.com/diseases-diagnoses/movement-disorders/friedreich-ataxia-pathophysiology-and-treatment/32041/Great strides have been made in understanding the pathophysiology of Friedreich ataxia, and a variety of treatments are available, including the first drug approved for Friedreich ataxia treatment in 2023.